Physician profile
Hector Banchs
NPI 1730496928
$132,349.76
in general payments reported to CMS, 2019-2025
21 companies · $5,941 in 2025
The $5,941 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,763 · 2020: $2,145 · 2021: $19K · 2022: $45K · 2023: $44K · 2024: $14K · 2025: $5,941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Travel and Lodging: $10K · Food and Beverage: $5,640 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,732.50 |
| Travel and Lodging | $10,249.66 |
| Food and Beverage | $5,640.37 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $50,200.21 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $36,515.75 | 2019-2025 | Farxiga, Wainua, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $22,120.74 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,638.35 | 2019-2025 | Lifevest |
| Abbott Laboratories | $6,190.86 | 2019-2024 | Aveir, Gallant, Mitraclip |
| Boston Scientific Corporation | $3,290.72 | 2019-2025 | General - Brady, Emblem Mri S-Icd, General - Tachy |
| Medtronic, INC. | $3,116.39 | 2019-2024 | Micra, Visa Af Mri Vr Surescan, Evera Mri Xt Dr Surescan |
| Merck Sharp & Dohme LLC | $1,218.38 | 2022-2025 | Steglatro, Verquvo, Capvaxive |
| Medtronic Vascular, INC. | $554.91 | 2019-2020 | |
| Celgene Corporation | $300.00 | 2022 | |
| Johnson and Johnson International | $295.56 | 2019-2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $256.49 | 2020-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $139.31 | 2020-2021 | |
| Akcea Therapeutics, INC. | $124.78 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $99.74 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $91.25 | 2021 | |
| Abiomed | $83.41 | 2024 | Impella |
| Pbg Puerto Rico LLC | $56.43 | 2019-2024 | |
| Scpharmaceuticals INC. | $21.43 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.05 | 2024 | |
| Pfizer INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Banchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.